Table 8. The serological response (the proportion of loss HBeAg ) in hepatitis B patients treated by TDF

Writer	3^rd month	6^th month	12^th month	18^th month
Manas K. Behera (2020)[13]	10%	34%	71%	84%
Dachuan Cai (2019) [14]	7.74%	8.92%	15.48%	24.18%
Rong-Yue Liang (2019) [15]	-	20.18%	-	-
Patrick Marcellin (2015) [17]	-	-	8.3%	14.7%
P. N. H. Tran (2013) [16]	-	-	19.1%	-
Our study (mono. group)	0%	0%	8%	21%
Our study (com. group)	0%	5%	19%	35%